A new CGM from Roche? What do we know?
Those who keep an eye on diabetes technology conferences will know that Roche are running an industry symposium at ATTD (Advanced Technology and Treatments for […]
“AID for pens”
Novo Nordisk acquisition of Biocorp. A big deal in the Smartpen world?
Novo Nordisk’s acquisition of Biocorp demonstrates how insulin manufacturers are looking to take the next step in optimising insulin delivery, opening up better access to AI techniques for MDI users.